IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Recruiting now · Phase 1/Phase 2
Conditions studied: NHL, Multiple Myeloma, Blood Cancer, Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
In brief
This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in combination with or without interleukin-2 (IL-2), and with or without isatuximab, daratumumab or rituximab to evaluate the safety, tolerability and preliminary antitumor activity in patients with advanced hematologic cancers.
Key facts
- Study ID
- NCT06119685
- Run by
- Indapta Therapeutics, INC.
- People needed
- 128
- Starts
- 2023-10-25
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2025-06-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- NEXT Oncology Virginia — Fairfax, Virginia, United States (enrolling)
- SCRI Oncology Partners — Nashville, Tennessee, United States (enrolling)
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States (enrolling)
- Valkyrie Clinical Trials — Los Angeles, California, United States (enrolling)
- Emory University Hospital — Atlanta, Georgia, United States (enrolling)
- University of Minnesota — Minneapolis, Minnesota, United States (enrolling)
- Atrium Health Wake Forest Baptist — Winston-Salem, North Carolina, United States (enrolling)
- University Hospitals Cleveland — Cleveland, Ohio, United States (enrolling)
- Rhode Island Hospital — Providence, Rhode Island, United States (enrolling)
- Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center — Lake Mary, Florida, United States
- NYP/Weill Cornell Medical Center — New York, New York, United States
- Providence Cancer Institute Franz Clinic — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.